Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease
Open accessThe DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.
Abstract
Gut microbiota shows host-specific diversity and temporal stability and significantly contributes to maintenance of a healthy gut. However, in inflammatory bowel disease, this microbiota has been implicated as a contributory factor to the illness. This study compared bacterial dynamics in Crohn's disease patients to those in a control group using a culture-independent method to assess the temporal stability, relative diversity, and similarity of the dominant fecal microbiota, Clostridium spp., Bacteroides spp., Bifidobacterium spp., and lactic acid bacteria spp. (LAB) for all individuals. Fecal samples were collected over several time points from individuals with Crohn's disease who were in remission ( n = 11), from Crohn's disease patients who relapsed into an active Crohn's disease state ( n = 5), and from a control group ( n = 18). Denaturing gradient gel electrophoresis profiles were generated for the different microbial groups by specifically targeting different regions of the 16S rRNA gene and were compared on the basis of similarity and diversity. The temporal stability of dominant species for all Crohn's disease patients was significantly lower ( P < 0.005) than that for the control group. Analysis of group-specific profiles for Bifidobacterium spp. found that they were similar in all samples, while the diversity of the LAB varied significantly between the groups, but temporal stability was not significantly altered. We observed significant changes in two functionally important mutualistic groups of bacteria, viz., Clostridium and Bacteroides spp., which may have implications for the host's gut health, since some genera are involved in production of short-chain fatty acid, e.g., butyrate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In fact, as with IBS (tables 2 and 3), faecal166–171 and mucosal-associated dysbiosis167 172–178 has been described IBD.”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 48,949
SIMPSON, E. H. (1949) · Nature · doi:10.1038/163688a0 · Cited by 14,164
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Phylogenetic identification and in situ detection of individual microbial cells without cultivation
Amann, R., Ludwig, W., & SCHLEIFER, K. H. (1995) · Microbiological Reviews · doi:10.1128/mmbr.59.1.143-169.1995 · Cited by 9,093
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“In this exploratory investigation, we report on the temporal stability and diversity of the dominant bacterial species, the Bacteroides fragilis subgroup (which is involved in metabolism of indigestible dietary polysaccharides [2] and may play a role in inflammatory bowel disease [30]), the Clostridium leptum subgroup…”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Research works printed but not linked: 2
- Boclé, J.-C., and C. Thomann. 2005. Effects of probiotics and prebiotics on flora and immunity in adults, p. 59-128. In L'Agence Française de Sécurité Sanitaire des Aliments report. L'Agence Française de Sécurité Sanitaire des Aliments, Maisons-Alfort, France.
- Sambrook, J., and D. Russell. 2000. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Cited by
Items 101–200 of 332
Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences
Salem, F., Kindt, N., Marchesi, J. R., Netter, P., Lopez, A., Kokten, T., Danese, S., Jouzeau, J.-Y., Peyrin-Biroulet, L., & Moulin, D. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619867555 · Cited by 103
“2014 16S rRNA sequencing Faecal samples 25 ERA 13 Controls (14/11) (6/7) 13 (7-19) 13 (6-18) USA - F.”
InfluentialSelf-citationWalujkar, S. A., Dhotre, D. P., Marathe, N. P., Lawate, P. S., Bharadwaj, R. S., & Shouche, Y. S. (2014) · Gut Pathogens · doi:10.1186/1757-4749-6-22 · Cited by 105
“[2,14,16-19].”
Microbial host interactions in IBD: Implications for pathogenesis and therapy
Sartor, R. B., & Muehlbauer, M. (2007) · Current Gastroenterology Reports · doi:10.1007/s11894-007-0066-4 · Cited by 123
Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth
Engevik, M. A., Aihara, E., Montrose, M. H., Shull, G. E., Hassett, D. J., & Worrell, R. T. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00184.2013 · Cited by 105
“3 Introduction: 48 The alteration of normal gut microbiota is known to play a role in a variety of complex diseases such as 49 obesity (85), (51), (52), (86), (2), (84), (3), diabetes (9), (47), Inflammatory Bowel Disease (28), (30), (68), 50 (56), (70), Antibiotic-associated diarrhea (92) and Clostridium difficile-as…”
BackgroundCulture-independent analysis of bacterial diversity in a child-care facility
Lee, L., Tin, S., & Kelley, S. T. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-27 · Cited by 117
Bacterial protein signals are associated with Crohn’s disease
Juste, C., Kreil, D. P., Beauvallet, C., Guillot, A., Vaca, S., Carapito, C., Mondot, S., Sykacek, P., Sokol, H., Blon, F., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303786 · Cited by 98
Characterization of the Gastrointestinal Microbiota in Health and Inflammatory Bowel Disease
De Cruz, P., Prideaux, L., Wagner, J., Ng, S. C., McSweeney, C., Kirkwood, C., Morrison, M., & Kamm, M. A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21751 · Cited by 95
“versus controls, Bacteroidetes and its species has been found to be both increased(128,131,133,144,145,151,166,167) and decreased.(3,136,142,148,155) Increased numbers of Fusobacteria have been found in the FAM(140) and MAM(158) of active UC compared with inactive UC and controls.”
Gut microbiome interventions in human health and diseases
Nie, P., Li, Z., Wang, Y., Zhang, Y., Zhao, M., Luo, J., Du, S., Deng, Z., Chen, J., Wang, Y., et al. (2019) · Medicinal Research Reviews · doi:10.1002/med.21584 · Cited by 99
Mechanisms of Microbe–Host Interaction in Crohn’s Disease: Dysbiosis vs. Pathobiont Selection
Buttó, L. F., Schaubeck, M., & Haller, D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00555 · Cited by 93
Kim, E. S., Tarassishin, L., Eisele, C. D., Barré, A., Nair, N. K., Rendon, A. P., Hawkins, K. A., Debebe, A., White, S. R., Thjømøe, A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.050 · Cited by 101
Marchesi, J. R. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02574.x · Cited by 91
“…in the context of the gut microbiota as an environmental factor in functional gastrointestinal diseases, for example, inflammatory bowel disease (Scanlan et al., 2006; Frank et al., 2007), colorectal cancer (Scanlan et al., 2008b; Sobhani et al., 2011), irritable bowel syndrome (Kassinen et…”
BackgroundSelf-citationMicrobial biofilms and gastrointestinal diseases
von Rosenvinge, E. C., O'May, G. A., Macfarlane, S., Macfarlane, G. T., & Shirtliff, M. E. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12020 · Cited by 92
“The stability of bacterial diversity over time, particularly during active CD episodes and relapses, in patients with CD is lower than that in healthy controls (Scanlan et al., 2006).”
BackgroundThe fecal microbiota as a biomarker for disease activity in Crohn’s disease
Tedjo, D. I., Smolinska, A., Savelkoul, P. H. M., Masclee, A., van Schooten, F., Pierik, M. J., Penders, J., & Jonkers, D. M. A. E. (2016) · Scientific Reports · doi:10.1038/srep35216 · Cited by 98
“Although previous studies reported an association between specific bacterial taxa and disease severity, others were not able to find such differences 16,17,19–22, 24, 39 .”
The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review
Aldars‐García, L., Marín, A. C., Chaparro, M., & Gisbert, J. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063076 · Cited by 98
Tuber melanosporum, when dominant, affects fungal dynamics in truffle grounds
Napoli, C., Mello, A., Borra, A., Vizzini, A., Sourzat, P., & Bonfante, P. (2009) · New Phytologist · doi:10.1111/j.1469-8137.2009.03053.x · Cited by 86
Evidence for the involvement of infectious agents in the pathogenesis of Crohn’s disease
Hertogh, G. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.845 · Cited by 94
Enteric pathogens through life stages
Kolling, G. L., Wu, M., & Guerrant, R. L. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00114 · Cited by 98
“Loss of microbial diversity and richness, especially in members of clostridial cluster IV (e.g., Faecalibacterium prausnitzii), was observed in Crohn’s disease patients (Martinez-Medina et al., 2006; Scanlan et al., 2006; Frank et al., 2007; Sokol et al., 2008; Cucchiara et al., 2009).”
BackgroundNOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
“preponderance of certain Bacteroidetes and reduced complexity of the Firmicutes phylum [19,20].”
BackgroundHinkle, E., Tran, H., Bundy, J. W., Moreno, R., Miller, P. S., & Burkey, T. E. (2013) · Journal of Animal Science · doi:10.2527/jas.2011-4874 · Cited by 109
“Biodiversity of the fecal microbial populations in progeny derived from P1 vs. P4 dams were determined by analyzing the DGGE profiles with Shannon’s and Simpson’s ecological indexes of diversity as described by Scanlan et al. (2006).”
MethodBacteria in the pathogenesis of inflammatory bowel disease
Subramanian, S., Campbell, B. J., & Rhodes, J. M. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244054.69253.f3 · Cited by 79
Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease
Sun, L., Nava, G. M., & Stappenbeck, T. S. (2011) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834661b4 · Cited by 75
Liu, J., Wu, D., Ahmed, A., Li, X., Ma, Y., Tang, L., Mo, D., Ma, Y., & Xin, Y. (2012) · Current Microbiology · doi:10.1007/s00284-012-0105-8 · Cited by 73
Yvon, S., Olier, M., Leveque, M., Jard, G., Tormo, H., Haimoud-Lekhal, D. A., Peter, M., & Eutamène, H. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1304-z · Cited by 75
“As compared to healthy subjects, alteration of the gut microbiota profile of CD patients is observed and is notably characterized by an imbalance of the ratios between the two major phyla Firmicutes and Bacteroidetes [9, 10].”
BackgroundRadulovic, K., Normand, S., Rehman, A., Delanoye, A., Chatagnon, J., Delacre, M., Waldschmitt, N., Poulin, L. F., Iovanna, J., Ryffel, B., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.87 · Cited by 74
Segal, J. P., Mullish, B. H., Quraishi, M. N., Acharjee, A., Williams, H. R. T., Iqbal, T. H., Hart, A. L., & Marchesi, J. R. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284818822250 · Cited by 77
Self-citationZeng, L., Yang, K., He, Q., Zhu, X., Long, Z., Wu, Y., Chen, J., Li, Y., Zeng, J., Cui, G., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03303-4 · Cited by 80
“In addition, intestinal flora imbalance is associated with Crohn’s disease activity and disease progression [302–304], and intestinal flora is a key factor in postoperative recurrence of Crohn’s disease [305, 306], but there are also views that intestinal flora alterations in the composition and…”
BackgroundBretin, A., Lucas, C., Larabi, A. B., Dalmasso, G., Billard, E., Barnich, N., Bonnet, R., & Nguyen, H. T. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-30055-y · Cited by 77
Lamb, C. A., Saifuddin, A., Powell, N., & Rieder, F. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.077 · Cited by 72
Rea, M. C., Alemayehu, D., Ross, R. P., & Hill, C. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.058933-0 · Cited by 76
Bacterial Flora in Inflammatory Bowel Disease
Marteau, P. (2009) · Digestive Diseases · doi:10.1159/000268128 · Cited by 63
“The dominant microbiota of healthy subjects appears relatively stable (at least for the dominant groups over time), with high biodiversity and resilience after disturbances (e.g. after antibiotic treatment) [ , , ,”
BackgroundFaecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease
Galazzo, G., Tedjo, D. I., Wintjens, D., Savelkoul, P. H. M., Masclee, A., Bodelier, A. G. L., Pierik, M. J., Jonkers, D. M. A. E., & Penders, J. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz049 · Cited by 72
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
Xu, X., Ocansey, D. K. W., Hang, S., Wang, B., Amoah, S., Yi, C., Zhang, X., Liu, L., & Mao, F. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00499-9 · Cited by 82
“At the phylum level, the bacteria community structure of IBD patients had reduced levels of Firmicutes, Bacteroides, Fusobacteria, and Tenericutes but increased abundance of Proteobacteria and Actinobacteria compared with healthy controls.”
ResultInfluentialSpecific metabolite production by gut microbiota as a basis for probiotic function
Ross, R. P., Mills, S., Hill, C., Fitzgerald, G. F., & Stanton, C. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.12.003 · Cited by 67
The Microbiota in Inflammatory Bowel Disease in Different Age Groups
Cucchiara, S., Iebba, V., Conte, M. P., & Schippa, S. (2009) · Digestive Diseases · doi:10.1159/000228558 · Cited by 60
RetractedComposition and stability of intestinal microbiota of healthy children within a Dutch population
de Meij, T. G. J., Budding, A. E., de Groot, E. F. J., Jansen, F. M., Kneepkens, C. M. F., Benninga, M. A., Penders, J., Bodegraven, A. A. V., & Savelkoul, P. H. M. (2015) · The FASEB Journal · doi:10.1096/fj.15-278622 · Cited by 78
Jia, J., Cheng, M., Xue, X., Guan, Y., & Wang, Z. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110182 · Cited by 63
Molecular Characterization of Fecal Microbiota in Patients with Viral Diarrhea
Ma, C., Wu, X., Nawaz, M., Li, J., Yu, P., Moore, J. E., & Xu, J. (2011) · Current Microbiology · doi:10.1007/s00284-011-9972-7 · Cited by 60
“TM (IMPLEN, Germany) [ 23 ]. PCR Amplification for DGGE”
BackgroundTeofani, A., Marafini, I., Laudisi, F., Pietrucci, D., Salvatori, S., Unida, V., Biocca, S., Monteleone, G., & Desideri, A. (2022) · Nutrients · doi:10.3390/nu14020260 · Cited by 71
Comparison of oral microbiota in orthodontic patients and healthy individuals
Sun, F., Ahmed, A., Wang, L., Dong, M., & Niu, W. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.08.011 · Cited by 61
Seksik, P. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70020-8 · Cited by 73
Microbial evolution and ecological opportunity in the gut environment
Scanlan, P. D. (2019) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2019.1964 · Cited by 61
Self-citationCrosstalk between gut microbiota and gut resident macrophages in inflammatory bowel disease
Zhang, H., Wang, X., Zhang, J., He, Y., Yang, X., Nie, Y., & Sun, L. (2023) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2023-0123 · Cited by 63
Robinson, A. M., Gondalia, S. V., Karpe, A. V., Eri, R. D., Beale, D. J., Morrison, P. D., Palombo, E. A., & Nurgali, K. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000970 · Cited by 60
Tanno, H., Fujii, T., Hirano, K., Maeno, S., Tonozuka, T., Sakamoto, M., Ohkuma, M., Tochio, T., & Endo, A. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1869503 · Cited by 63
Gut microbiota in the early stage of Crohn’s disease has unique characteristics
Ma, X., Lu, X., Zhang, W., Yang, L., Wang, D., Xu, J., Jia, Y., Wang, X., Xie, H., Li, S., et al. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00521-0 · Cited by 65
Zhang, C., Xu, Y.-X., Wu, S. L., Zheng, W., Song, S., & Ai, C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.02.057 · Cited by 54
Yin, J., Zhang, X., Wu, B., & Xian, Q. (2015) · Ecotoxicology · doi:10.1007/s10646-015-1540-7 · Cited by 55
Durand, G. A., Pham, T., Ndongo, S., Traore, S. I., Dubourg, G., Lagier, J., Michelle, C., Armstrong, N., Fournier, P., Raoult, D., et al. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.12.001 · Cited by 52
Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10−/− Mice
Ye, J., Lee, J. W., Presley, L. L., Bent, E., Wei, B., Braun, J. G., Schiller, N. L., Straus, D. S., & Borneman, J. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20442 · Cited by 55
Yan, Y., Li, K., Jiang, J., Jiang, L., Ma, X., Ai, F., Qiu, S., & Si, W. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03263-1 · Cited by 51
“Previous studies have also shown that the diversity of gut microbiota is reduced in IBD patients, and Ruminococcus gnavus and adherent invasive Escherichia coli have been linked to IBD and gut inflammation [13, 14].”
ResultSarbini, S. R., Kolida, S., Gibson, G. R., & Rastall, R. A. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512004205 · Cited by 50
Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases
Comito, D., & Romano, C. (2012) · International Journal of Inflammation · doi:10.1155/2012/687143 · Cited by 48
“Numerous studies have analysed microbial compositions in individuals with IBD compared to healthy controls analyzing stool samples, but it is well accepted that microbial populations from stool differ from those associated with the mucosa [51–54].”
BackgroundNovel Microbiome-Based Therapeutics for Chronic Rhinosinusitis
Cope, E. K., & Lynch, S. V. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0504-y · Cited by 55
The Bowel Microbiota and Inflammatory Bowel Diseases
Tannock, G. W. (2010) · International Journal of Inflammation · doi:10.4061/2010/954051 · Cited by 63
“Scanlan et al.[53], for example, reported that they failed to detect members of clostridial cluster IV in 27% of CD fecal samples (PCR) but all control samples contained these bacteria (P < .”
ResultSamanta, A. K., Torok, V. A., Percy, N. J., Abimosleh, S. M., & Howarth, G. S. (2012) · The Journal of Microbiology · doi:10.1007/s12275-012-1362-8 · Cited by 49
Matamouros, S., Hayden, H. S., Hager, K. R., Brittnacher, M., Lachance, K., Weiss, E. J., Pope, C. E., Imhaus, A., McNally, C. P., Borenstein, E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714373115 · Cited by 55
“However, in Crohn’s disease, where fat absorption is compromised similar to CF, elevated levels of glycerol and depletion of antimicrobial SCFAs are two prominent features of these patients’ fecal samples (30).”
BackgroundBecker, H. E. F., Jamin, C., Bervoets, L., Boleij, A., Xu, P., Pierik, M. J., Stassen, F. R. M., Savelkoul, P. H. M., Penders, J., & Jonkers, D. M. A. E. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.598232 · Cited by 52
The Presystemic Interplay between Gut Microbiota and Orally Administered Calycosin-7-O-β-d-Glucoside
Ruan, J., Li, S., Li, Y., Wu, W., Lee, S. M., & Yan, R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065094 · Cited by 48
Intestinal Dendritic Cells and Epithelial Barrier Dysfunction in Crohnʼs Disease
Silva, M. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20660 · Cited by 48
The role of the immune system in regulating the microbiota
Willing, B. P., Gill, N., & Finlay, B. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12520 · Cited by 54
Host-bacteria interaction in inflammatory bowel disease
Knight, P., Campbell, B. J., & Rhodes, J. M. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn038 · Cited by 46
Berding, K., & Donovan, S. M. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00193 · Cited by 43
The search for disease-associated compositional shifts in bowel bacterial communities of humans
Tannock, G. W. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.07.005 · Cited by 47
Bacteria in the pathogenesis of inflammatory bowel disease
Flanagan, P. K., Campbell, B. J., & Rhodes, J. M. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391067 · Cited by 44
Kopper, J. J., Iennarella‐Servantez, C. A., Jergens, A. E., Sahoo, D. K., Guillot, E., Bourgois‐Mochel, A., Martinez, M. N., Allenspach, K., & Mochel, J. P. (2021) · Frontiers in Toxicology · doi:10.3389/ftox.2021.773953 · Cited by 48
Integrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease
Su, F., Su, M., Wei, W., Wu, J., Chen, L., Sun, X., Liu, M., Sun, S., Mao, R., Bourgonje, A. R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2476570 · Cited by 44
Mańkowska-Wierzbicka, D., Stelmach-Mardas, M., Gabryel, M., Tomczak, H., Skrzypczak-Zielińska, M., Zakerska-Banaszak, O., Sowińska, A., Mahadea, D., Baturo, A., Wolko, Ł., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8080268 · Cited by 39
Influences of Intestinal Bacteria in Human Inflammatory Bowel Disease
Vanderploeg, R., Panaccione, R., Ghosh, S., & Rioux, K. P. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.008 · Cited by 43
Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes
Liñares-Blanco, J., Fernandez-Lozano, C., Seoane, J. A., & López–Campos, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.872671 · Cited by 42
“…disease (IBD) (Franzosa et al., 2019; Lloyd-Price et al., 2019; Amoroso et al., 2020; Ananthakrishnan, 2020; De Musis et al., 2020; Glassner et al., 2020; Haifer et al., 2020; Aldars-García et al., 2021), including ulcerative colitis (Guo et al., 2020) and Crohn’s disease (Scanlan et al., 2006).”
BackgroundGut microbiota and eye diseases: a bibliometric study and visualization analysis
Fu, X., Tan, H., Huang, L., Chen, W., Ren, X. Z., & Chen, D. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1225859 · Cited by 45
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei
Gilbreath, J. J., Semino‐Mora, C., Friedline, C. J., Liu, H., Bodi, K. L., McAvoy, T. J., Francis, J., Nieroda, C. A., Sardi, A., Dubois, A., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-105 · Cited by 41
“Within the past several years, it has become increasingly clear that the microbial communities in and on the human body have a far-reaching impact on human physiology and serve to maintain the balance between health and disease states [11-21].”
Lepczyńska, M., & Dzika, E. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0287-8 · Cited by 43
Wei, X., Zhang, L., Zhang, R., Koci, M. D., Si, D., Ahmad, B., Cheng, J., Wang, J., Aihemaiti, M., & Zhang, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01361 · Cited by 40
“(40) who speculated that the decrease in Firmicutes and Bacteriodetes may be related to the occurrence of intestinal inflammation.”
BackgroundNagalingam, N. A., Robinson, C. J., Bergin, I. L., Eaton, K. A., Huffnagle, G. B., & Young, V. B. (2013) · Microbiome · doi:10.1186/2049-2618-1-15 · Cited by 35
“IBD is also associated with an altered microbiota, often exhibited by patients as a reduction in diversity of the intestinal microbial community compared to healthy participants [44-47].”
BackgroundLeifer, C. A., McConkey, C., Li, S., Chassaing, B., Gewirtz, A. T., & Ley, R. E. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.07.017 · Cited by 34
Wu, D., Hou, C., Li, Y., Zhao, Z., Liu, J., Lu, X., Shang, X., & Xin, Y. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-179 · Cited by 37
“Pi is the proportion of species/bands for the ith species/band in the sample [17].”
BackgroundPu, W., Zhang, H., Zhang, T., Guo, X., Wang, X., & Tang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1004756 · Cited by 36
Host–pathobiont interactions in Crohn’s disease
Caruso, R., Lo, B. C., Chen, G., & Núñez, G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00997-y · Cited by 44
“Collectively, such studies showed a decreased microbial diversity and a shift in certain bacterial taxa, including a decrease in certain taxa of strict anaerobes and an increase in members of the Enterobacteriaceae family 113–120 (Table 1).”
Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases
Selin, K., Hedin, C. R. H., & Villablanca, E. J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab085 · Cited by 39
Exploring Links Between Industrialization, Urbanization, and Chinese Inflammatory Bowel Disease
Cui, G., Liu, H., Xu, G., Laugsand, J.-B., & Pang, Z. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757025 · Cited by 41
Rasmussen, H. E., Martínez, I., Lee, J. Y., & Walter, J. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2009.04288.x · Cited by 32
“To determine the microbial diversity in the colon, Shannon’s and Simpson’s ecological indices were applied to the molecular fingerprints obtained with DGGE as described by Scanlan and co-workers (Scanlan et al. 2006).”
MethodIshaq, H. M., Yasin, R., Mohammad, I. S., Yang, F., Li, H., Shahzad, M., & Xu, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30494 · Cited by 35
“Primer Sequence (5 1 – 3 evaluated using NanoPhotometer TM (Germany) [23].”
MethodGut-Thyroid axis: How gut microbial dysbiosis associated with euthyroid thyroid cancer
Ishaq, H. M., Mohammad, I. S., Hussain, R., Parveen, R., Shirazi, J. H., Yang, F., Shahzad, M., Hayat, K., Li, H., Ihsan, A., et al. (2022) · Journal of Cancer · doi:10.7150/jca.66816 · Cited by 37
“The first step of bead-beating was conducted for ½ min with 5000 rpm. Concentration of DNA was evaluated using Nano Photometer TM (IMPLEN, Germany) [28].”
Klüber, P., Meurer, S. K., Lambertz, J., Schwarz, R., Zechel-Gran, S., Braunschweig, T. A., Hurka, S., Domann, E., & Weiskirchen, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313156 · Cited by 36
“In particular, there is a characteristic change in the ratio of the phyla Firmicutes and Bacterioidetes as well as an increase in Enterobacteriaceae associated with the pathogenesis of CD [12,13].”
BackgroundHygiene, microbial diversity and immune regulation
Guarner, F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282eeb43b · Cited by 37
Vidal, R. M., Ginard, D., Khorrami, S., Mora-Ruiz, M. D. R., Muñoz, R., Hermoso, M. A., Díaz, S. C., Cifuentes, A., Orfila, A., & Rossello-Mora, R. A. (2015) · Systematic and Applied Microbiology · doi:10.1016/j.syapm.2015.06.008 · Cited by 31
Li, W., Han, L., Yu, P., Ma, C., Wu, X., & Xu, J. (2014) · Microbiological Research · doi:10.1016/j.micres.2014.02.008 · Cited by 30
“From the UPGMA lustering analysis of V3-DGGE (Fig.”
MethodInfluentialYang, B. K., Yan, S., Chen, Y., Ross, R. P., Stanton, C., Zhao, J., Zhang, H., & Chen, W. (2020) · Microorganisms · doi:10.3390/microorganisms8081108 · Cited by 36
Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population
Mikelsaar, M., Sepp, E., Štšepetova, J., Songisepp, E., & Mändar, R. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_3 · Cited by 32
“…Tensia and in urine of volunteers consuming the probiotic cheeses Hydrogen sulfide is produced in the gut by sulfide-reducing bacteria (main genus Desulfovibrio) via the reduction of diet-derived sulfate and the metabolism of sulfur amino acids and taurine (Magee et al. 2000; Scanlan et al. 2006).”
BackgroundBach, L., Ram, A., Ijaz, U. Z., Evans, T. J., & Lindström, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.573969 · Cited by 29
The Gut Microbiome and Pre-systemic Metabolism: Current State and Evolving Research
Grundmann, O. (2010) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000104 · Cited by 28
NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation
Anderson, J. M., Lipinski, S., Sommer, F., Pan, W.-H., Boulard, O., Rehman, A., Falk‐Paulsen, M., Stengel, S. T., Aden, K., Häsler, R., et al. (2020) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.03.008 · Cited by 29
Lopetuso, L. R., Napoli, M., Rizzatti, G., & Gasbarrini, A. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1483333 · Cited by 30
Shin, S. Y., Kim, Y., Kim, W.-S., Moon, J. M., Lee, K., Jung, S.-A., Park, H., Huh, E. Y., Kim, B. C., Lee, S. C., et al. (2022) · Intestinal Research · doi:10.5217/ir.2021.00168 · Cited by 30
Chakraborty, P., Banerjee, D., Majumder, P., & Sarkar, J. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100104 · Cited by 29
The antigenic link between thyroid autoimmunity and breast cancer
Muller, I., & Barrett-Lee, P. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.013 · Cited by 27
Panigrahi, P. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i47.6370 · Cited by 26
“Denaturing gradient gel electrophoresis can be utilized to monitor changes in microflora pattern [ 69 ,70]”
MethodKolora, L. D., Powell, C. M., Hunter, W. B., Bextine, B. R., & Lauzon, C. R. (2015) · Current Microbiology · doi:10.1007/s00284-015-0774-1 · Cited by 25
“, [31]); however, in some cases, they can be predicted by knowing the composition of the indigenous”
BackgroundMicrobiome-Linked Crosstalk in the Gastrointestinal Exposome towards Host Health and Disease
Moon, Y. (2016) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2016.19.4.221 · Cited by 27
“testinal microbial diversity in IBD patients may be decreased [14,15].”
Rationale for probiotic treatment strategies in inflammatory bowel disease
Schultz, M., & Lindström, A. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.3.337 · Cited by 30
Metadata
- Authors
- Scanlan, P. D., Shanahan, F., O'Mahony, C., & Marchesi, J. R.
- Affiliations
- National University of Ireland (IE)
- Alimentary Pharmabiotic Centre, National University of Ireland, University College Cork, Cork, Ireland
- Corresponding author
- Marchesi, Julian R.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2006-11
- Volume
- 44
- Issue
- 11
- Pages
- 3980-3988
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC1698357
- OpenAlex
- W2144413511
- Cited by
- 330
- References
- 72
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 26 · 2023: 12 · 2022: 18 · 2021: 12 · 2020: 16 · 2019: 15 · 2018: 20 · 2017: 11 · 2016: 16 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 24
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Update notices
- correction (2007-05-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Crohn's disease, gut microbiota, fecal microbiota, temporal stability, inflammatory bowel disease, Clostridium, Bacteroides, Bifidobacterium, lactic acid bacteria, remission, recurrence, microbial diversity, 16S rRNA gene, short-chain fatty acids, butyrate
- MeSH terms
- Adult, Aged, Bacteria, Bacteroides fragilis, Bifidobacterium, Clostridium, Crohn Disease, Feces, Female, Humans, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.